Personal automation for whole genome sequencing: evaluating digital microfluidics across two different PCR-free protocols.
Solving the problem of rare: automated microfluidics for accurate variant detection by PCR-free WGS of very small human samples
Success of initial Miro Canvas Beta program leading to expanded access and increased protocol availability
Laboratory automation firm Miroculus said on Thursday that it has completed a Series B financing extension bringing the total capital raised in the round to $45 million.
Miroculus, Inc., a developer of revolutionary tools for personal lab automation, today announced the completion of a Series B extension, bringing the total capital raised in the series to $45M.
Dr. Keith Robison's post-AGBT insights about Miroculus and the promise of Miro Technology.
Twist Bioscience and Miroculus Agree to Collaborate on Next-Generation Sequencing Target Enrichment and Library Preparation Tools for Clinical Research
Twist Bioscience and Miroculus agree to collaborate on next-generation sequencing target enrichment and library preparation tools for clinical research.
Miroculus launches digital microfluidics sample prep system at AGBT, explores new applications.
Utilizing a novel microfluidic technology to optimize enzymatic DNA synthesis for information storage application.
Conjugating DNA onto magnetic beads for iterative sample analysis.